🇺🇸 FDA

Drug profile · INN

methotrexate

JYLAMVO

approved L04AX03
US status
approved
Patents linked
8
News articles
0

Quick answer

methotrexate (JYLAMVO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN methotrexate
Brand JYLAMVO
Route ORAL
Formulation SOLUTION
ATC code L04AX03

Related patents

Search patents →

  1. US 12246064

    Method of treating Crohn's disease by administering a triple combination therapy of anti-integrin antibody, adalimumab and methotrexate

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12005061

    Ophthalmic formulations of methotrexate

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12005060

    Ophthalmic formulations of methotrexate

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11911385

    Methotrexate treatment methods

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11253604

    Conjugate of methotrexate and peptide

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10028911

    Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9770414

    Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8865728

    Combinations comprising methotrexate and DHODH inhibitors

    Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is methotrexate?

methotrexate (JYLAMVO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for methotrexate?

JYLAMVO is a marketed brand name for methotrexate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of methotrexate?

methotrexate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.